(38) has shown that cells isolated from bronchoalveolar lavage of intensive care unit (ICU) patients with severe COVID-19 cases were enriched with tumour growth factor-beta 1 (TGF-β1)-expressing Th17, regulatory T cells, and CD14-positive cells, immune cells that are usually recruited to fight the infection. This evidence concerns the gene TGFB1 and COVID-19.